Professor Matt Trau

An internationally recognised research scientist, recognised for innovative and cross-disciplinary research at the interface between chemistry, nanotechnology, biology and medicine.

Matt has held positions in industry and academia across the globe and has also been a consultant for a range of national and international companies such as Merck, Digene, Beckman Coulter and Panbio.

Over the last 10 years Matt has raised greater than $25m of research funding to support his work and has initiated and led several large international consortia that involve close collaboration between leading nanotechnologists, molecular biologists, geneticists, clinicians and commercial researchers – with the goal of creating cutting edge diagnostics.

• University of Queensland
• Director, Centre for Personalised Nanomedicine
• Professor of Chemistry, School of Chemistry & Molecular Biosciences

2004-2009
ARC Federation Fellow

2008 
Visiting Scientist, Fred Hutchinson Cancer Research Ctr, Seattle

2000
Visiting Professor, Harvard Uni, Dana Farber Cancer Inst, Boston

1993-1997
Fulbright Research Fellow, Dept of Chemical Engineering & Princeton Materials Institute, Princeton University

1991
British Council Scholar to the UK, University College, London

1987-1988
Research Scientist, ICI Research Centre (Advanced Polymer Division)

1983-84
Research Scientist, Dow Chemical Research Centre (Analytical Division), Melbourne